ValuationViz

RLAY fund manager activity

Relay Therapeutics, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q2 2021 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Stanley Druckenmiller - Duquesne Family OfficeNew349,000$6,530,0000.15%Aug 14, 2026
Joel Greenblatt - Gotham Asset ManagementSold out——0.00%Aug 14, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Joel Greenblatt - Gotham Asset ManagementNew33,606$334,3800.00%May 15, 2026

Older quarters